Used as a pharmacopoeial reference standard for analytical testing. Employed in impurity profiling of doxylamine drug substances and formulations. Utilized in method development validation and system suitability testing for chromatographic analyses. Applied in stability studies to assess product degradation pathways. Supports compliance with European Pharmacopoeia and other regulatory quality requirements.

The primary purpose of Doxylamine EP Impurity B is to provide a reference material for the identification quantification and control of related substances in doxylamine-containing pharmaceutical products thereby ensuring product quality safety consis

Doxylamine EP Impurity B is a specified related substance recognized in the European Pharmacopoeia (EP) monograph for Doxylamine. It represents a known process-related or degradation impurity that may occur during the synthesis manufacturing storage or stability testing of doxylamine pharmaceutical products.